Riva Sheppard - May 25, 2023 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role: Co-Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Riva Sheppard
Stock symbol: INBP
Transactions as of: May 25, 2023
Transactions value $: $1,368,705
Form type: 4
Date filed: 9/21/2023, 04:17 PM
Previous filing: Nov 10, 2022
Next filing: Jun 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INBP	Common Stock	Award	$1.36M	+3.41M	+21723.01%	$0.40	3.43M	May 25, 2023	As Co-Executor of the Estate of E Gerald Kay and as Trustee of the Emily Sheppard Trust	F1, F2, F3
transaction	INBP	Common Stock	Award	$4.5K	+50K	+4.09%	$0.09^*	1.27M	Sep 20, 2023	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBP	Stock Option (right to buy)	Award	$0	+150K		$0.00	150K	May 25, 2023	Common Stock	150K	$0.23	As Co-Executor of the Estate of E Gerald Kay	F1, F5
transaction	INBP	Stock Option (right to buy)	Award	$0	+66.7K		$0.00	66.7K	May 25, 2023	Common Stock	66.7K	$0.72	As Co-Executor of the Estate of E Gerald Kay	F1, F6
transaction	INBP	Stock Option (right to buy)	Award	$0	+21.7K		$0.00	21.7K	May 25, 2023	Common Stock	21.7K	$1.05	As Co-Executor of the Estate of E Gerald Kay	F1
transaction	INBP	Stock Option (right to buy)	Disposed to Issuer	$0	-50K	-20%	$0.00	200K	Sep 20, 2023	Common Stock	50K	$0.09	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay.
F2	Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay.
F3	3,410,512 as Co-Executor of the Estate of E Gerald Kay and 15,700 as Trustee to the Emily Sheppard Trust.
F4	50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F5	25,000 vested on May 24, 2019 and 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022.
F6	33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date.